Can cerebellar ataxia cause loss of sphincter control, leading to urinary or fecal incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Cerebellar Ataxia Cause Loss of Sphincter Control?

Pure cerebellar ataxia alone does not typically cause loss of sphincter control; however, when sphincter dysfunction occurs alongside cerebellar ataxia, it strongly suggests a diagnosis other than isolated cerebellar disease—most notably Multiple System Atrophy (MSA) or other conditions affecting multiple neurological systems.

Key Diagnostic Distinction

The presence or absence of sphincter dysfunction is critical for differential diagnosis:

  • Isolated cerebellar disease (pure spinocerebellar ataxias) rarely causes significant sphincter dysfunction 1, 2
  • MSA with cerebellar features (MSA-C) presents with the combination of cerebellar ataxia, pyramidal signs, and dysautonomia including urinary incontinence in the majority of cases 1
  • MSA typically has onset between 55-65 years of age with mean disease duration of approximately 6 years 1

Urinary Dysfunction in Spinocerebellar Ataxias

While traditionally not considered a primary feature, lower urinary tract symptoms (LUTS) do occur in spinocerebellar ataxias more frequently than previously recognized:

  • 15% of patients with genetically confirmed SCAs have LUTS 3
  • When present, urinary frequency is the most common symptom (72.7% of those with LUTS), followed by voiding difficulty 3
  • In SCA6 specifically, urinary symptoms occur in 56% of patients, with urinary frequency in 33% 4
  • Storage and voiding symptoms are reported in 86.3% of SCA patients when systematically assessed with validated questionnaires, though often mild 5

Urodynamic Findings in SCAs

When urodynamic studies are performed in SCA patients with urinary complaints:

  • Detrusor overactivity occurs in approximately 11-21% 3, 4
  • Detrusor underactivity during voiding phase is common 5
  • Post-void residual >100ml occurs in some patients 3
  • Neurogenic bladder changes can be documented 3
  • True urinary retention is rare 4

Clinical Implications and Red Flags

When to Suspect MSA Rather Than Pure SCA

The combination of cerebellar ataxia with significant urinary incontinence should raise immediate concern for MSA rather than isolated cerebellar disease 1. MSA is distinguished by:

  • Abnormal cytoplasmic inclusions of alpha-synuclein in oligodendroglia 1
  • Progressive autonomic dysfunction including urinary incontinence 1
  • Often coexisting Parkinsonian features 1

Bowel Dysfunction

  • Fecal incontinence is a "white flag" indicating severe neurological compromise when present with cauda equina syndrome 6
  • In SCAs, bowel symptoms are less common (31.4%) and tend to be mild 5
  • Significant bowel dysfunction with cerebellar ataxia suggests pathology beyond the cerebellum

Diagnostic Approach

Initial Imaging

  • MRI of the head without IV contrast is the preferred initial imaging modality for evaluating cerebellar ataxia 6, 2
  • MRI provides superior visualization of the posterior fossa and can detect morphologic changes and signal alterations in cerebellum and brainstem 6, 2
  • Look for patterns suggesting MSA versus isolated cerebellar atrophy 1, 2

Laboratory Evaluation When Sphincter Dysfunction Present

Test for autoimmune and paraneoplastic causes when cerebellar ataxia occurs with autonomic dysfunction:

  • GAD antibodies 1
  • Glycine receptor antibodies (GlyR-Abs) 1
  • CASPR2 antibodies 1
  • Voltage-gated calcium channel antibodies (VGCC-Abs) 1
  • Screen for underlying malignancy, particularly lung cancer in older patients 1

Management Considerations

Treatment of Urinary Symptoms

  • 77.6% of SCA patients with urinary symptoms report impact on quality of life, yet 55.3% receive no pharmacological treatment 5
  • These symptoms are frequently overlooked due to focus on primary neurological manifestations 5
  • A multidisciplinary approach including urology consultation should be adopted 5

Immunotherapy-Responsive Conditions

When autoimmune etiology is identified:

  • Patients with GlyR-Abs respond well to intravenous immunoglobulins and corticosteroids 1
  • Early immunotherapy is critical to prevent permanent cerebellar damage in paraneoplastic syndromes 1

Clinical Pitfall

The most important pitfall is misdiagnosing MSA-C as a pure spinocerebellar ataxia when urinary dysfunction is present 3. A patient with progressive cerebellar ataxia without family history who develops significant urinary incontinence should be evaluated for MSA rather than assumed to have hereditary SCA 3.

References

Guideline

Diagnostic Approach to Cerebellar Ataxia and Dysautonomia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cerebellar Atrophy Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lower Urinary Tract Function in Spinocerebellar Ataxia 6.

Lower urinary tract symptoms, 2012

Research

Lower urinary tract and bowel dysfunction in spinocerebellar ataxias.

Annals of clinical and translational neurology, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the management plan for a patient with cerebellar ataxia, a history of smoking, and potential vertebrobasilar insufficiency?
How is ataxia classified by time?
How is cerebellar ataxia managed when unsteadiness occurs regardless of eye position?
Is cerebellar ataxia a central nervous system (CNS) disease?
What is the appropriate management for a patient with acute cerebellar infarcts, dyslipidemia, normal MRA findings, and ataxia, presenting with headache and dizziness?
How does magnesium sulfate work for seizure prophylaxis in patients with a history of eclampsia or severe preeclampsia?
What is the recommended management for an adult patient with acute ischemic stroke, history of stroke or stroke risk factors, and MRI findings of hyperintensity in T2 FLAIR?
What medication should be added for an elderly female patient with type 2 diabetes mellitus (T2DM) and impaired glycemic control, as indicated by an increased Hemoglobin A1C (HbA1C) from 7.3 to 7.9, who is currently on metformin (Metformin) and Januvia (Sitagliptin)?
What is the appropriate management and ICD10 code for a patient with a normal heart rhythm, normal ejection fraction, normal left atrium, concentric hypertrophy of the left ventricle, and mild mitral valve regurgitation, likely with a history of hypertension?
Should a patient with a mechanical valve and a history of cardiac disease have their Coumadin (warfarin) dose lowered due to an elevated PT/INR level?
What type of antibiotic is cephalexin, specifically for pediatric patients with cellulitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.